Name
antihypertensive_n
Label
Number of anti-hypertensives?
Units
medications
Type
numeric
Visit number vs Number of anti-hypertensives?
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 318 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 318 |
Follow-up | 300 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | 1 | 301 |
Treatment Arm vs Number of anti-hypertensives?
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 318 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 318 |
HLSE | 106 | 2.3 | ± 1.3 | 2.0 | 0.0 | 7.0 | - | 106 |
HLSE-O | 106 | 2.5 | ± 1.3 | 2.0 | 0.0 | 6.0 | - | 106 |
HLSE-P | 106 | 2.3 | ± 1.5 | 2.0 | 0.0 | 6.0 | - | 106 |
Treatment Arm vs Number of anti-hypertensives?
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 300 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | 1 | 301 |
HLSE | 100 | 2.3 | ± 1.2 | 2.0 | 0.0 | 5.0 | - | 100 |
HLSE-O | 101 | 2.5 | ± 1.4 | 2.0 | 0.0 | 6.0 | - | 101 |
HLSE-P | 99 | 2.3 | ± 1.6 | 2.0 | 0.0 | 6.0 | 1 | 100 |
Age category vs Number of anti-hypertensives?
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 318 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 318 |
45-54 years | 53 | 2.0 | ± 1.2 | 2.0 | 0.0 | 5.0 | - | 53 |
55-64 years | 139 | 2.5 | ± 1.5 | 2.0 | 0.0 | 7.0 | - | 139 |
65 years or older | 126 | 2.4 | ± 1.3 | 2.0 | 0.0 | 6.0 | - | 126 |
Age category vs Number of anti-hypertensives?
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 300 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | - | 300 |
45-54 years | 49 | 2.0 | ± 1.2 | 2.0 | 0.0 | 5.0 | - | 49 |
55-64 years | 127 | 2.4 | ± 1.5 | 2.0 | 0.0 | 6.0 | - | 127 |
65 years or older | 124 | 2.5 | ± 1.3 | 2.0 | 0.0 | 6.0 | - | 124 |
Gender vs Number of anti-hypertensives?
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 318 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 318 |
Female | 84 | 2.0 | ± 1.2 | 2.0 | 0.0 | 5.0 | - | 84 |
Male | 234 | 2.5 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 234 |
Gender vs Number of anti-hypertensives?
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 300 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | 1 | 301 |
Female | 79 | 2.0 | ± 1.3 | 2.0 | 0.0 | 5.0 | - | 79 |
Male | 221 | 2.5 | ± 1.4 | 2.0 | 0.0 | 6.0 | 1 | 222 |
Race vs Number of anti-hypertensives?
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 313 | 2.4 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 313 |
White | 252 | 2.3 | ± 1.4 | 2.0 | 0.0 | 7.0 | - | 252 |
Black | 42 | 2.7 | ± 1.4 | 2.5 | 0.0 | 6.0 | - | 42 |
Other | 19 | 2.0 | ± 1.3 | 2.0 | 0.0 | 4.0 | - | 19 |
Race vs Number of anti-hypertensives?
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 296 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | - | 296 |
White | 237 | 2.4 | ± 1.4 | 2.0 | 0.0 | 6.0 | - | 237 |
Black | 40 | 2.7 | ± 1.4 | 3.0 | 0.0 | 5.0 | - | 40 |
Other | 19 | 2.0 | ± 1.4 | 2.0 | 0.0 | 5.0 | - | 19 |